Works matching IS 16197070 AND DT 2024 AND VI 52 AND IP 1

Results: 37
    1
    2
    3

    Specific imaging of CD8 + T-Cell dynamics with a nanobody radiotracer against human CD8β.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 193, doi. 10.1007/s00259-024-06896-3
    By:
    • De Groof, Timo W.M.;
    • Lauwers, Yoline;
    • De Pauw, Tessa;
    • Saxena, Mohit;
    • Vincke, Cécile;
    • Van Craenenbroeck, Jolien;
    • Chapon, Catherine;
    • Le Grand, Roger;
    • Raes, Geert;
    • Naninck, Thibaut;
    • Van Ginderachter, Jo A.;
    • Devoogdt, Nick
    Publication type:
    Article
    4
    5

    [<sup>99m</sup>Tc]Tc-hydroxydiphosphonate uptake in soft tissue is associated with amyloid load in subcutaneous abdominal fat tissue and mortality in wild-type transthyretin amyloidosis patients.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 88, doi. 10.1007/s00259-024-06865-w
    By:
    • Tingen, Hendrea Sanne Aletta;
    • Groothof, Dion;
    • Tubben, Alwin;
    • Bijzet, Johan;
    • Houwerzijl, Ewout J.;
    • Muntinghe, Friso L. H.;
    • van der Zwaag, Paul A.;
    • van der Meer, Peter;
    • Hazenberg, Bouke P. C.;
    • Slart, Riemer H. J. A.;
    • Nienhuis, Hans L. A.
    Publication type:
    Article
    6
    7
    8

    Spatial and temporal tracking of multi-layered cells sheet using reporter gene imaging with human sodium iodide symporter: a preclinical study using a rat model of myocardial infarction.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 74, doi. 10.1007/s00259-024-06889-2
    By:
    • Otani, Kentaro;
    • Zeniya, Tsutomu;
    • Kawashima, Hidekazu;
    • Moriguchi, Tetsuaki;
    • Nakano, Atsushi;
    • Han, Chunlei;
    • Murata, Shunsuke;
    • Nishimura, Kunihiro;
    • Koshino, Kazuhiro;
    • Yamahara, Kenichi;
    • Inubushi, Masayuki;
    • Iida, Hidehiro
    Publication type:
    Article
    9

    Efficacy and safety of rechallenge with [<sup>177</sup>Lu]Lu-PSMA-I&T radioligand therapy in metastatic castration resistant prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 354, doi. 10.1007/s00259-024-06905-5
    By:
    • Santo, Giulia;
    • Di Santo, Gianpaolo;
    • Sviridenko, Anna;
    • Bayerschmidt, Steffen;
    • Wirth, Lukas;
    • Scherbauer, Fabian;
    • Lehmann, Peter;
    • von Guggenberg, Elisabeth;
    • Decristoforo, Clemens;
    • Heidegger-Pircher, Isabel;
    • Bektic, Jasmin;
    • Virgolini, Irene
    Publication type:
    Article
    10
    11

    EANM guidelines on the use of [<sup>18</sup>F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 171, doi. 10.1007/s00259-024-06858-9
    By:
    • Nanni, Cristina;
    • Deroose, Christophe M.;
    • Balogova, Sona;
    • Lapa, Constantin;
    • Withofs, Nadia;
    • Subesinghe, Manil;
    • Jamet, Bastien;
    • Zamagni, Elena;
    • Ippolito, Davide;
    • Delforge, Michel;
    • Kraeber-Bodéré, Francoise
    Publication type:
    Article
    12
    13

    Detection of tumour heterogeneity in patients with advanced, metastatic castration-resistant prostate cancer on [<sup>68</sup>Ga]Ga-/[<sup>18</sup>F]F-PSMA-11/-1007, [<sup>68</sup>Ga]Ga-FAPI-46 and 2-[<sup>18</sup>F]FDG PET/CT: a pilot study.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 342, doi. 10.1007/s00259-024-06891-8
    By:
    • Pabst, Kim M.;
    • Mei, Riccardo;
    • Lückerath, Katharina;
    • Hadaschik, Boris A.;
    • Kesch, Claudia;
    • Rawitzer, Josefine;
    • Kessler, Lukas;
    • Bodensieck, Luisa S.;
    • Hamacher, Rainer;
    • Pomykala, Kelsey L.;
    • Fanti, Stefano;
    • Herrmann, Ken;
    • Fendler, Wolfgang P.
    Publication type:
    Article
    14
    15
    16

    Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 326, doi. 10.1007/s00259-024-06887-4
    By:
    • Giunta, Emilio Francesco;
    • Caroli, Paola;
    • Scarpi, Emanuela;
    • Altavilla, Amelia;
    • Rossetti, Virginia;
    • Marini, Irene;
    • Celli, Monica;
    • Casadei, Chiara;
    • Lolli, Cristian;
    • Schepisi, Giuseppe;
    • Bleve, Sara;
    • Brighi, Nicole;
    • Cursano, Maria Concetta;
    • Paganelli, Giovanni;
    • Matteucci, Federica;
    • De Giorgi, Ugo
    Publication type:
    Article
    17
    18
    19
    20

    Preclinical evaluation of the novel [<sup>18</sup>F]CHDI-650 PET ligand for non-invasive quantification of mutant huntingtin aggregates in Huntington's disease.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 122, doi. 10.1007/s00259-024-06880-x
    By:
    • Zajicek, Franziska;
    • Verhaeghe, Jeroen;
    • De Lombaerde, Stef;
    • Van Eetveldt, Annemie;
    • Miranda, Alan;
    • Munoz-Sanjuan, Ignacio;
    • Dominguez, Celia;
    • Khetarpal, Vinod;
    • Bard, Jonathan;
    • Liu, Longbin;
    • Staelens, Steven;
    • Bertoglio, Daniele
    Publication type:
    Article
    21
    22
    23
    24
    25
    26

    Standardized template for clinical reporting of PSMA PET/CT scans.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 335, doi. 10.1007/s00259-024-06857-w
    By:
    • Esfahani, Shadi A.;
    • Morris, Michael J.;
    • Sartor, Oliver;
    • Frydenberg, Mark;
    • Fanti, Stefano;
    • Calais, Jeremie;
    • Vapiwala, Neha
    Publication type:
    Article
    27
    28

    The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [<sup>177</sup>Lu]Lu-DOTATATE.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 291, doi. 10.1007/s00259-024-06863-y
    By:
    • Maccauro, Marco;
    • Cuomo, Mariarosaria;
    • Bauckneht, Matteo;
    • Bagnalasta, Matteo;
    • Mazzaglia, Stefania;
    • Scalorbi, Federica;
    • Argiroffi, Giovanni;
    • Kirienko, Margarita;
    • Lorenzoni, Alice;
    • Aliberti, Gianluca;
    • Pusceddu, Sara;
    • Giuseppina, Calareso;
    • Matteo, Garanzini Enrico;
    • Seregni, Ettore;
    • Chiesa, Carlo
    Publication type:
    Article
    29
    30
    31

    Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [<sup>18</sup>F]FDG PET/CT: a systematic review and individual patient data meta-analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 225, doi. 10.1007/s00259-024-06860-1
    By:
    • Willemse, Jeroen R. J.;
    • Lambregts, Doenja M. J.;
    • Balduzzi, Sara;
    • Schats, Winnie;
    • Snaebjornsson, Petur;
    • Marchetti, Serena;
    • Vollebergh, Marieke A.;
    • van Golen, Larissa W.;
    • Cheung, Zing;
    • Vogel, Wouter V.;
    • Bodalal, Zuhir;
    • Rostami, Sajjad;
    • Gerke, Oke;
    • Sivakumaran, Tharani;
    • Beets-Tan, Regina G.H.;
    • Lahaye, Max J.
    Publication type:
    Article
    32
    33

    Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [<sup>68</sup>Ga]Ga-PSMA-11 PET scans of primary prostate cancer.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 305, doi. 10.1007/s00259-024-06856-x
    By:
    • Rupp, Niels J.;
    • Freiberger, Sandra N.;
    • Ferraro, Daniela A.;
    • Laudicella, Riccardo;
    • Heimer, Jakob;
    • Muehlematter, Urs J.;
    • Poyet, Cédric;
    • Moch, Holger;
    • Eberli, Daniel;
    • Rüschoff, Jan H.;
    • Burger, Irene A.
    Publication type:
    Article
    34

    The association of quantitative PSMA PET parameters with pathologic ISUP grade: an international multicenter analysis.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 314, doi. 10.1007/s00259-024-06847-y
    By:
    • Soeterik, Timo F. W.;
    • Heetman, Joris G.;
    • Hermsen, Rick;
    • Wever, Lieke;
    • Lavalaye, Jules;
    • Vinken, Maarten;
    • Bahler, Clinton D.;
    • Yong, Courtney;
    • Tann, Mark;
    • Kesch, Claudia;
    • Seifert, Robert;
    • Telli, Tugce;
    • Chiu, Peter Ka-Fung;
    • Wu, Kwan Kit;
    • Zattoni, Fabio;
    • Evangelista, Laura;
    • Segalla, Emma;
    • Barone, Antonio;
    • Ceci, Francesco;
    • Rajwa, Pawel
    Publication type:
    Article
    35
    36
    37